Rabeprazole and Vicodin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole (rabeprazole sodium) and Vicodin (acetaminophen; hydrocodone bitartrate). Common drug interactions include discomfort among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Rabeprazole and Vicodin. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Vicodin?

Vicodin has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 63,357 Vicodin users. Check the latest studies of Vicodin.



On Jul, 08, 2026

69 people who take Rabeprazole and Vicodin together, and have interactions are studied.

Rabeprazole and Vicodin drug interactions.

What are the common drug interactions of Rabeprazole and Vicodin, by gender? *:

female:

  1. Discomfort
  2. Eating disorder
  3. Emotional distress
  4. Gingivitis (inflammation of gums)
  5. Injury
  6. Neuropathy peripheral (surface nerve damage)
  7. Osteomyelitis (infection of bone)
  8. Pain in jaw
  9. Parotitis (inflammation of a parotid gland)
  10. Periodontal disease (disease that attacks the gum and bone and around the teeth)

male:

  1. Dizziness
  2. Fall
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Chest pain
  5. Chronic kidney disease
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  8. Dyspnoea (difficult or laboured respiration)
  9. Epistaxis (bleed from the nose)
  10. Eructation (release of gas from the digestive tract)

What are the common drug interactions of Rabeprazole and Vicodin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Anxiety
  5. Chest wall pain
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Eye rolling
  8. Injection site burning
  9. Muscle twitching
  10. Nervousness

40-49:

  1. Swelling face
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Asthenia (weakness)
  5. Deformity (disfigurement)
  6. Dental caries
  7. Discomfort
  8. Eating disorder
  9. Emotional distress
  10. Gingivitis (inflammation of gums)

50-59:

  1. Disease recurrence
  2. Headache (pain in head)
  3. Hyperlipidaemia (presence of excess lipids in the blood)
  4. Hypertension (high blood pressure)
  5. Spinal osteoarthritis (joint cartilage loss in spine)
  6. Weight increased
  7. Abdominal distension
  8. Abdominal hernia
  9. Abortion spontaneous (naturally occurring miscarriage)
  10. Alanine aminotransferase increased

60+:

  1. Blood urea increased
  2. Exostosis (formation of new bone on the surface of a bone)
  3. Anxiety
  4. Blood creatinine increased
  5. Fatigue (feeling of tiredness)
  6. Hypertension (high blood pressure)
  7. Injury
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Oedema peripheral (superficial swelling)
  10. Pain in extremity

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 17 people, 24.64%
  2. Multiple Myeloma (cancer of the plasma cells): 11 people, 15.94%
  3. Insomnia (sleeplessness): 6 people, 8.70%
  4. High Blood Pressure: 5 people, 7.25%
  5. Stress And Anxiety: 4 people, 5.80%
  6. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and Vicodin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rabeprazole and Vicodin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vicodin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vicodin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium and acetaminophen; hydrocodone bitartrate (the active ingredients of Rabeprazole and Vicodin, respectively), and Rabeprazole and Vicodin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: